Financials data is unavailable for this security.
View more
Year on year Organon & Co had relatively flat revenues (6.17bn to 6.26bn), though the company grew net income 11.56% from 917.00m to 1.02bn.
| Gross margin | 58.26% |
|---|---|
| Net profit margin | 20.30% |
| Operating margin | 12.20% |
| Return on assets | 10.95% |
|---|---|
| Return on equity | -- |
| Return on investment | 14.08% |
More ▼
Cash flow in USDView more
In 2023, Organon & Co did not generate a significant amount of cash. However, the company earned 799.00m from its operations for a Cash Flow Margin of 12.76%. In addition the company used 260.00m on investing activities and also paid 569.00m in financing cash flows.
| Cash flow per share | 6.04 |
|---|---|
| Price/Cash flow per share | 2.46 |
| Book value per share | 1.91 |
|---|---|
| Tangible book value per share | -18.92 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.70 |
|---|---|
| Quick ratio | 1.21 |
| Total debt/total equity | 17.75 |
|---|---|
| Total debt/total capital | 0.9467 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 11.08%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 22.83% |
| EPS growth(5 years) | -14.04 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 120.60 |
More ▼
